The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKakuzi Regulatory News (KAKU)

Share Price Information for Kakuzi (KAKU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 92.50
High: 0.00
Low: 0.00
Prev. Close: 92.50
KAKU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

25 Aug 2023 07:00

RNS Number : 3899K
Kakuzi Ld
25 August 2023
 

KAKUZI PLC

 

 

EXTRACT FROM THE INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD OF SIX MONTHS TO 30 JUNE 2023

The unaudited results for the Kakuzi Group for the period of six months to 30 June 2023 and the comparative figures for the previous year are as follows:

 

Condensed Consolidated Statement of Profit or Loss and other Comprehensive Income

 

 

 

 

 

 

 

 

 

 

 

 

 

30 June 2023

 

30 June 2022

 

 

 

 

 

Shs'000

 

Shs'000

 

 

 

Sales

873,155

1,026,492

 

Profit before fair value gain in non-current biological assets and income tax

149,528

471,842

  Fair value gain in non-current biological assets

21,591

22,826

 

 

Profit before income tax

171,119

494,668

Income tax expense

(53,621

)

(153,398

)

Profit for the period

117,498

341,270

  Other Comprehensive Income:

Items that are not reclassified to profit or loss:

Remeasurement of post-employment benefit obligations (net of tax)

-

-

Total comprehensive income

117,498

341,270

 

Shs

 

Shs

 

 

Earnings per share (Shs):

 

 

 

 

 

Basic and diluted earnings per ordinary share

5.99

17.41

 

Condensed Consolidated Statement of Financial Position

 

 

 

 

 

 

 

 

 

Audited

 

 

 

 

 

 

30 June 2023

 

30 June 2022

 

31 December 2022

 

 

 

 

 

 

Shs'000

 

Shs'000

 

Shs'000

 

EQUITY

Share capital

98,000

98,000

98,000

Other reserves

32,815

37,991

32,815

Retained earnings

5,465,134

5,313,502

5,347,636

Proposed dividends

-

-

470,400

Total equity

5,595,949

5,449,493

5,948,851

Non-current liabilities

1,203,079

1,098,845

1,187,237

6,799,028

6,548,338

7,136,188

REPRESENTED BY

Non-current assets

4,097,646

3,999,063

4,089,669

Cash and cash balances

239,675

840,966

1,408,744

Other current assets

2,842,579

2,259,249

1,983,022

Current liabilities

(380,872

)

(550,940

)

(345,247

)

Net current assets

2,701,382

2,549,275

3,046,519

6,799,028

6,548,338

7,136,188

 

 

Condensed Consolidated Statement of Cash flows

 

 

 

 

 

 

 

 

 

 

 

 

 

30 June 2023

 

30 June 2022

 

 

 

 

 

Shs'000

 

Shs'000

 

 

 

Cash and cash equivalents at the beginning of the period

1,408,744

1,656,219

 

Net cash used in operating activities

(597,169

)

(188,424

)

Net cash used in investing activities

(159,841

)

(225,311

)

Net cash used in financing activities

(470,400

)

(431,201

)

Effect of exchange rate differences on cash and cash equivalents

58,341

29,683

Decrease in cash and cash equivalents

(1,169,069

)

(815,253

)

Cash and cash equivalents at the end of the period

239,675

840,966

 

 

 

Condensed Consolidated Statement of Changes in Equity

 

 

 

 

 

 

Share

capital

 

Other reserves

 

Retained earnings

 

Proposed dividends

 

Total Equity

 

 

Shs'000

 

Shs'000

 

Shs'000

 

Shs'000

 

Shs'000

 

 

 

 

 

 

 

 

 

 

 

 

At start of the period

98,000

32,815

5,347,636

470,400

5,948,851

Profit for the period

-

-

117,498

-

117,498

Dividends paid

-

-

-

(470,400

)

(470,400

)

 

At end of period

98,000

32,815

5,465,134

-

5,595,949

 

 

KEY HIGHLIGHTS

·  Avocado profits have more than doubled in 2023 to Ksh 654.8 million, up from Ksh 288.6 million in 2022

·  Global Macadamia glut persists leading to a Kshs 329 million sectoral loss for the macadamia business

·  Recovery expected as Kakuzi Macadamia domestic market retail sales efforts doubled up to mitigate international market risks

·  Pretax profit down by 65% to Ksh 171.1 million from Kshs 494.7 million

·  Avocado exports to China up on last year.

 

TRADING PERFORMANCE

 

The half-year trading period for the financial year 2023 are in line with our expectations given the challenging macadamia markets. As highlighted at the Annual General Meeting, we expect the global macadamia glut situation to persist throughout the balance of 2023 financial year and may be into 2024.

In 2022 the half year profits for the macadamia business were posted at Ksh 339 million. This year the situation has reversed to a loss of Ksh (329) million. The disappointment is that in our biggest markets of China, Japan and the USA, the same quality macadamia nut kernels are now selling for less than half the price recorded during the same period last year even as production volumes from all source markets continue to grow.

 

We remain committed to a shared prosperity business model that prioritizes all our stakeholder needs. Growing our business in a sustainable manner, actively implementing our Kakuzi, Community Partnerships, answering the call for climate action and using best practices in all we do to promote our values remains our focus.

 

The Directors do not recommend the payment of an Interim Dividend.

 

BY ORDER OF THE BOARD

NICHOLAS NG'ANG'A

CHAIRMAN

24 AUGUST 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BUGDIBUDDGXS
12
Date   Source Headline
20th Mar 20248:27 amRNSAnnual Financial Report
6th Dec 20237:00 amRNSProfit Warning Announcement
25th Aug 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSAnnual Financial Report
19th Aug 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSAnnual Financial Report
6th Jan 20227:00 amRNS2021 PROFIT WARNING ANNOUNCEMENT
18th Aug 20217:00 amRNSHalf-year Report
22nd Mar 20217:00 amRNSAnnual Financial Report - Replacement
19th Mar 20217:00 amRNSAnnual Financial Report
2nd Nov 20207:00 amRNSDirectorate Change
19th Aug 20207:00 amRNSHalf-year Report
26th May 20207:00 amRNSAGM Statement
9th Apr 20207:00 amRNSDividend Declaration
20th Mar 20207:00 amRNSAnnual Financial Report
19th Feb 20207:00 amRNSDeath Of Director
15th Aug 20197:00 amRNSHalf-year Report
29th Mar 20197:00 amRNSAnnual Financial Report
15th Aug 20187:00 amRNSHalf-year Report
23rd Mar 20187:00 amRNSAnnual Financial Report
7th Aug 20177:00 amRNSHalf-year Report
29th Mar 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSAnnual Financial Report
3rd Aug 20167:00 amRNSDirectorate Change
3rd Aug 20167:00 amRNSHalf-year Report
17th Mar 20167:00 amRNSAnnual Financial Report
12th Aug 20157:00 amRNSHalf Yearly Report
27th May 20157:00 amRNSDirectorate Change
25th Mar 20157:00 amRNSAnnual Financial Report
27th Aug 20147:00 amRNSHalf Yearly Report
19th Mar 20147:00 amRNSFinal Results
27th Nov 20137:00 amRNSPROFIT WARNING
27th Aug 20137:00 amRNSHalf Yearly Report
2nd Apr 20137:00 amRNSDirectorate Change
2nd Apr 20137:00 amRNSAnnual Financial Report
30th Nov 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSProfit Warning Announcement
31st Aug 20127:00 amRNSInterim Financial Statements
22nd Aug 20127:00 amRNSDisposal
2nd Apr 20127:00 amRNSFinal results for the year ended 31 Dec 2011
7th Feb 20127:00 amRNSPublic Announcement
30th Aug 20117:11 amRNSHalf Yearly Report
18th Mar 20118:03 amRNSFinal Results 2010 Replacement
18th Mar 20117:39 amRNSFinal Results 2010
26th Jan 20117:00 amRNSPublic Announcement
25th Aug 20104:55 pmRNSHalf Yearly Report
12th Mar 20107:00 amRNSFinal Results
26th Aug 20097:00 amRNSHalf Yearly Report
5th Mar 20094:21 pmRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.